Log in to save to my catalogue

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endo...

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2491440621

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome

About this item

Full title

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome

Publisher

New York: Springer US

Journal title

Stem cell reviews and reports, 2021-02, Vol.17 (1), p.266-277

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Angiotensin-converting enzyme 2 (ACE2) plays an important role as a member of the renin–angiotensin–aldosterone system (RAAS) in regulating the conversion of angiotensin II (Ang II) into angiotensin (1–7) (Ang [1–7]). But at the same time, while expressed on the surface of human cells, ACE2 is the entry receptor for SARS-CoV-2. Expression of this r...

Alternative Titles

Full title

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2491440621

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2491440621

Other Identifiers

ISSN

2629-3269

E-ISSN

2629-3277

DOI

10.1007/s12015-020-10010-z

How to access this item